Affiliation:
1. Department of Biostatistics GSK Rixensart Belgium
2. Institute of Mathematics Swiss Federal Institute of Technology Lausanne (EPFL) Lausanne Switzerland
Abstract
AbstractTraditional vaccine efficacy trials usually use fixed designs and often require large sample sizes. Recruiting a large number of subjects can make the trial expensive, long, and difficult to conduct. A possible approach to reduce the sample size and speed up the development is to use historical controls. In this paper, we extend the robust mixture prior (RMP) approach (a well established approach for Bayesian dynamic borrowing of historical controls) to adjust for covariates. The adjustment is done using classical methods from causal inference: inverse probability of treatment weighting, G‐computation and double‐robust estimation. We evaluate these covariate‐adjusted RMP approaches using a comprehensive simulation study and demonstrate their use by performing a retrospective analysis of a prophylactic human papillomavirus vaccine efficacy trial. Adjusting for covariates reduces the drift between current and historical controls, with a beneficial effect on bias, control of type I error and power.
Funder
GlaxoSmithKline Biologicals
Reference36 articles.
1. The combination of randomized and historical controls in clinical trials;Pocock SJ;J Chron Dis,1976
2. Power prior distributions for regression models;Ibrahim JG;Statistical Science,2000
3. Evaluating water quality using power priors to incorporate historical data;Duan Y;Environ,2006
4. A note on the power prior;Neuenschwander B;Stat Med,2009
5. Summarizing historical data on controls in clinical trials;Neuenschwander B;Clin Trial,2010